Latest News

AAAAI 2025: Omalizumab Shows Favorable Outcomes Versus Oral Immunotherapy in Multi‐Food Allergy Treatment / Image credit: ©bit24/AdobeStock
AAAAI 2025: Omalizumab Shows Favorable Outcomes Versus Oral Immunotherapy in Multi‐Food Allergy Treatment

February 12th 2025

In a randomized clinical trial, omalizumab achieved a 36% treatment success rate for multi-food allergy compared with 19% for oral immunotherapy.

Transdermal Peanut Patch Shows Increased Benefit Over 5-Year Study / image credit ©Stepan Popov/stock.adobe.com
Transdermal Peanut Patch Shows Increased Clinical Benefit Over 5-Year Study

February 12th 2025

Minimally Invasive Esophageal String Test Used to Monitor Eosinophilic Esophagitis in Children / Image credit: ©Naeblys/AdobeStock
Minimally Invasive Esophageal String Test Used to Monitor Eosinophilic Esophagitis in Children

January 27th 2025

ACG Updates Guidelines for Eosinophilic Esophagitis: Daily Dose / image credit: ©New Africa/AdobeStock
ACG Updates Guidelines for Eosinophilic Esophagitis: Daily Dose

January 16th 2025

Neffy Update: FDA to Review 1 mg Version in First Quarter 2025, for Young Children with Type 1 Allergic Reactions / image credit ©ARS Pharma
Neffy Update: FDA to Review 1 mg Version in First Quarter 2025, for Young Children with Type 1 Allergic Reactions

January 14th 2025

More News

© 2025 MJH Life Sciences

All rights reserved.